İ. DOĞAN Et Al. , "Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients," EUROPEAN JOURNAL OF BREAST HEALTH , vol.18, no.4, pp.323-328, 2022
DOĞAN, İ. Et Al. 2022. Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients. EUROPEAN JOURNAL OF BREAST HEALTH , vol.18, no.4 , 323-328.
DOĞAN, İ., Aydin, E., Yazici, H., & Saip, P., (2022). Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients. EUROPEAN JOURNAL OF BREAST HEALTH , vol.18, no.4, 323-328.
DOĞAN, İzzet Et Al. "Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients," EUROPEAN JOURNAL OF BREAST HEALTH , vol.18, no.4, 323-328, 2022
DOĞAN, İzzet Et Al. "Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients." EUROPEAN JOURNAL OF BREAST HEALTH , vol.18, no.4, pp.323-328, 2022
DOĞAN, İ. Et Al. (2022) . "Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients." EUROPEAN JOURNAL OF BREAST HEALTH , vol.18, no.4, pp.323-328.
@article{article, author={İzzet DOĞAN Et Al. }, title={Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients}, journal={EUROPEAN JOURNAL OF BREAST HEALTH}, year=2022, pages={323-328} }